Vittorio Colizzi

Q: What Schools Are Affiliated With Vittorio Colizzi

Vittorio Colizzi is affiliated with the following schools: University of Milan, University of Bologna

Vittorio Colizzi's AcademicInfluence.com Rankings

Vittorio Colizzi

Biology

#15811

World Rank

#19876

Historical Rank

Developmental Biology

#233

World Rank

#241

Historical Rank

Virology

#415

World Rank

#424

Historical Rank

Evolutionary Biology

#442

World Rank

#474

Historical Rank

biology Degrees

Download Badge

Biology

Vittorio Colizzi's Degrees

Masters Virology University of Milan
PhD Microbiology University of Bologna

Why Is Vittorio Colizzi Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Professor Vittorio Colizzi is an Italian virologist and one of the most eminent HIV/AIDS researchers in Europe. He directs the Immunochemical and Molecular Pathology laboratory in the biology department of Tor Vergata University in Rome. With his French colleague Luc Montagnier he has participated in many conferences, particularly in Africa, to combat the propagation of HIV.

(See a Problem?)

Vittorio Colizzi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antibacterial activity of alkaloids from Sida acuta (2006) (289)
APOPTOSIS OF HUMAN MONOCYTES/MACROPHAGES IN MYCOBACTERIUM TUBERCULOSIS INFECTION (1997) (169)
Traditional medicine: past, present and future research and development prospects and integration in the National Health System of Cameroon. (2011) (135)
Molecular Epidemiology: HIV-1 and HCV sequences from Libyan outbreak (2006) (135)
Lack of CD27−CD45RA−Vγ9Vδ2+ T Cell Effectors in Immunocompromised Hosts and During Active Pulmonary Tuberculosis1 (2002) (110)
Antioxidant and Anti-Inflammatory Activities of Extracts from Cassia alata, Eleusine indica, Eremomastax speciosa, Carica papaya and Polyscias fulva Medicinal Plants Collected in Cameroon (2014) (105)
Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. (2017) (90)
Role of dental plaque in the transmission of Helicobacter pylori infection. (1996) (85)
P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. (2006) (85)
Abusive use of antibiotics in poultry farming in Cameroon and the public health implications (2016) (77)
Drug-Induced Expansion and Differentiation of Vγ9Vδ2 T Cells In Vivo: The Role of Exogenous IL-21 (2005) (72)
Granulocytic Myeloid Derived Suppressor Cells Expansion during Active Pulmonary Tuberculosis Is Associated with High Nitric Oxide Plasma Level (2015) (64)
Antioxidant extracts of African medicinal plants induce cell cycle arrest and differentiation in B16F10 melanoma cells. (2013) (63)
The role of macrophage cell death in tuberculosis (1999) (63)
African Ethnopharmacology and New Drug Discovery (2007) (54)
Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption. (2002) (52)
Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon (2011) (50)
In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3&zgr; expression through ELF-1 inhibition (2015) (48)
MicroRNA from Moringa oleifera: Identification by High Throughput Sequencing and Their Potential Contribution to Plant Medicinal Value (2016) (47)
Dendritic cells derived from BCG‐infected precursors induce Th2‐like immune response (2004) (47)
Vδ1T Lymphocytes Expressing a Th1 Phenotype Are the Major γδ T Cell Subset Infiltrating the Liver of HCV-infected Persons (2001) (43)
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study (2021) (41)
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon (2011) (40)
Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2. (2005) (40)
Characterization of drug resistance mutations in naïve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon (2012) (38)
Characterization of drug‐resistance mutations in HIV‐1 isolates from non‐HAART and HAART treated patients in Burkina Faso (2006) (35)
In vivo γδ T Cell Priming to Mycobacterial Antigens by Primary Mycobacterium tuberculosis Infection and Exposure to Nonpeptidic Ligands (1999) (35)
Reference Values of Lymphocyte Subsets in Healthy, HIV-Negative Children in Cameroon (2011) (33)
Implementation of HIV early infant diagnosis and HIV type 1 RNA viral load determination on dried blood spots in Cameroon: challenges and propositions. (2012) (33)
Bioinformatics Prediction and Experimental Validation of MicroRNAs Involved in Cross-Kingdom Interaction (2016) (33)
Natural lysophospholipids reduce Mycobacterium tuberculosis‐induced cytotoxicity and induce anti‐mycobacterial activity by a phagolysosome maturation‐dependent mechanism in A549 type II alveolar epithelial cells (2010) (32)
Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance (2013) (30)
Effective program against mother‐to‐child transmission of HIV at Saint Camille Medical Centre in Burkina Faso (2007) (30)
Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008–2010: lessons and challenges for low-resource settings (2013) (28)
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians. (2016) (27)
HMGB1 and Cord Blood: Its Role as Immuno-Adjuvant Factor in Innate Immunity (2011) (27)
Reduction of mother‐to‐child transmission of HIV at Saint Camille Medical Centre in Burkina Faso (2006) (26)
Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients (2017) (25)
Influence of Pertussis toxin on CD1a Isoform Expression in Human Dendritic Cells (2006) (25)
Olea europaea small RNA with functional homology to human miR34a in cross-kingdom interaction of anti-tumoral response (2018) (24)
Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat” (2019) (23)
Human cord blood γδ T cells expressing public Vγ2 chains dominate the response to bisphosphonate plus interleukin‐15 (2013) (23)
Early Warning Indicators for HIV Drug Resistance in Cameroon during the Year 2010 (2012) (23)
Cytotoxic and apoptotic effects of different extracts of Moringa oleifera Lam on lymphoid and monocytoid cells (2019) (23)
Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy. (2011) (22)
Vδ2 T‐lymphocyte responses in cord blood samples from Italy and Côte d’Ivoire (2008) (22)
Cord blood Vγ2Vδ2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. (2014) (22)
HIV-1 Early Infant Diagnosis is an Effective Indicator of the Prevention of Mother-to-Child Transmission Program Performance: Experience from Cameroon. (2015) (22)
HLA-A, -B and -DRB1 allele frequencies in Cyrenaica population (Libya) and genetic relationships with other populations. (2013) (21)
Effect of microvesicles from Moringa oleifera containing miRNA on proliferation and apoptosis in tumor cell lines (2020) (21)
A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: Implications for large scale monitoring of HIV‐infected patients in resource‐limited settings (2005) (20)
Mobile health clinic for the medical management of clinical sequelae experienced by survivors of the 2013–2016 Ebola virus disease outbreak in Sierra Leone, West Africa (2017) (20)
Non-Pathogenic Mycobacterium smegmatis Induces the Differentiation of Human Monocytes Directly into Fully Mature Dendritic Cells (2005) (19)
Seasonal pattern of hospitalization from acute respiratory infections in Yaoundé, Cameroon. (2010) (18)
Identification of microRNAs and relative target genes in Moringa oleifera leaf and callus (2019) (17)
Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling (2016) (17)
In vitro anti Mycobacterium tuberculosis H37Rv activity of Lannea acida A. Rich from Burkina Faso. (2011) (16)
An abnormal phenotype of lung Vγ9Vδ2 T cells impairs their responsiveness in tuberculosis patients. (2013) (16)
Water supply, sanitation and health risks in Douala 5 municipality, Cameroon. (2015) (16)
Validation of a single-platform, volumetric, flow cytometry for CD4 T cell count monitoring in therapeutic mobile unit (2012) (15)
Altered cord blood gammadelta T cell repertoire in Nigeria: possible impacts of environmental factors on neonatal immunity. (2008) (15)
Vγ9Vδ2 T-Cell Anergy and Complementarity-Determining Region 3-Specific Depletion during Paroxysm of Nonendemic Malaria Infection (2003) (15)
DNA HLA-DRB1 analysis in children of positive mothers and estimated risk of vertical HIV transmission. (1993) (15)
Use of Amplification Refractory Mutation System PCR Assay as a Simple and Effective Tool To Detect HIV-1 Drug Resistance Mutations (2015) (15)
Computer-Based Design of an HLA-Haplotype and HIV-Clade Independent Cytotoxic T-Lymphocyte (CTL) Assay for Monitoring HIV-Specific Immunity (2002) (14)
Differentiation of Monocytes Into CD1a− Dendritic Cells Correlates With Disease Progression in HIV-Infected Patients (2007) (14)
Evaluation of OraQuick® HIV-1/2 as Oral Rapid Test. (2013) (14)
HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaoundé, Cameroon: An Appeal for Revised Policies in Tropical Settings? (2016) (14)
Condom perception and prevention of HIV/AIDS infection in Cameroon: appraisal of knowledge, attitudes and practices among level one students of the University of Dschang. (2013) (13)
V gamma 9V delta 2 T-cell anergy and complementarity-determining region 3-specific depletion during paroxysm of nonendemic malaria infection. (2003) (13)
Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression. (2013) (13)
Genetic diversity in Ebola virus: Phylogenetic and in silico structural studies of Ebola viral proteins. (2016) (12)
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children (2018) (12)
The Vγ2/Vδ2 T‐cell repertoire in Macaca fascicularis: functional responses to phosphoantigen stimulation by the Vγ2/Jγ1.2 subset (2005) (12)
Structural Transformation to Attain Responsible BIOSciences (STARBIOS2): Protocol for a Horizon 2020 Funded European Multicenter Project to Promote Responsible Research and Innovation (2018) (11)
Low vaccine coverage among children born to HIV infected women in Niamey, Niger (2016) (11)
Effect of microvesicles from Moringa oleifera containing miRNA on proliferation and apoptosis in tumor cell lines. (2020) (11)
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns (2018) (11)
Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé (2019) (10)
Field Application of the Micro Biological Survey Method for a Simple and Effective Assessment of the Microbiological Quality of Water Sources in Developing Countries (2015) (10)
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon (2019) (10)
Thiopyrophosphoantigens: solid-phase synthesis and in vitro characterization of a new class of Vgamma9 Vdelta2 T cells activators. (2009) (10)
[Epidemiological distribution of HIV infection among pregnant women in the ten regions of Cameroon and strategic implications for prevention programs]. (2015) (9)
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens (2020) (9)
Plant microRNAs from Moringa oleifera Regulate Immune Response and HIV Infection (2021) (9)
Mother-to-Children Plasmodium falciparum Asymptomatic Malaria Transmission at Saint Camille Medical Centre in Ouagadougou, Burkina Faso (2014) (9)
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings. (2021) (9)
Innate-like γδ T cell responses to mycobacterium Bacille Calmette-Guerin using the public Vγ2 repertoire in Macaca fascicularis (2007) (9)
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children. (2010) (9)
Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study) (2019) (9)
Microbiological quality of water sources in the West region of Cameroon: quantitative detection of total coliforms using Micro Biological Survey method (2020) (8)
Amino acid mutations in Ebola virus glycoprotein of the 2014 epidemic (2015) (8)
Innate-like gammadelta T cell responses to mycobacterium Bacille Calmette-Guerin using the public V gamma 2 repertoire in Macaca fascicularis. (2007) (8)
CONCISE COMMUNICATIONS Phosphoantigen-Reactive Vg9Vd2 T Lymphocytes Suppress In Vitro Human Immunodeficiency Virus Type 1 Replication by Cell-Released Antiviral Factors Including CC Chemokines (1999) (7)
The Vgamma2/Vdelta2 T-cell repertoire in Macaca fascicularis: functional responses to phosphoantigen stimulation by the Vgamma2/Jgamma1.2 subset. (2005) (7)
Maternal age, infant age, feeding options, single/multiple pregnancy, type of twin sets and mother-to-child transmission of HIV. (2018) (6)
The microRNA analysis portal is a next-generation tool for exploring and analyzing miRNA-focused data in the literature (2021) (6)
Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines. (2016) (6)
Immunoinformatic Docking Approach for the Analysis of KIR3DL1/HLA-B Interaction (2013) (6)
Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain. (2014) (6)
Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon (2021) (5)
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon (2020) (5)
Key role of human leukocyte antigen in modulating human immunodeficiency virus progression: An overview of the possible applications. (2015) (5)
A Plea for Justice for Jailed Medical Workers (2006) (5)
Paediatric HIV infection in Western Africa: the long way to the standard of care. (2012) (4)
Role of individual's T‐cell immunome in controlling HIV‐1 progression (2014) (4)
Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol (2022) (4)
SMAC, a computational system to link literature, biomedical and expression data (2019) (4)
Vd2 T-lymphocyte responses in cord blood samples from Italy (2008) (4)
Evaluation of the nutritional status of infants from mothers tested positive to HIV/AIDS in the health district of Dschang, Cameroon (2014) (4)
Why Publishing the Journal of Public Health in Africa (2017) (4)
The 2018–2020 Ebola Outbreak in the Democratic Republic of Congo: A Better Response Had Been Achieved Through Inter-State Coordination in Africa (2021) (4)
Human Leucocyte Antigen Class I Diversity among Human Immunodeficiency Virus Exposed Negative and Positive Children in Cameroon. (2015) (4)
Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon (2020) (4)
Characterization of Asymptomatic Children Infected with the Human Immunodeficiency Virus at Birth (2015) (4)
Knowledge, attitudes and practices on HIV / AIDS in the south region of Cameroon: case of the town of Kribi. (2014) (4)
Knowledge and Attitudes of Population Living in Rural and Semi-Rural Areas towards Covid-19 :Case of the Menoua Division, Cameroon. (2020) (4)
Youth Awareness on Sexually Transmitted Infections, HIV and AIDS in Secondary Schools in the Dschang Municipality (Cameroon): The Mobile Caravan Project (2016) (4)
Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon (2020) (4)
Mycobacteria and dendritic cell differentiation: escape or control of immunity. (2005) (4)
Hepatitis B infection and risk factors among children living with HIV in Yaounde, Cameroon: an integrated management (2019) (4)
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol (2020) (3)
Prevalence of HIV, HBV and chlamydia infections in Cameroonian University context: case of the University of Dschang, in the Western region (2014) (3)
197 Population Level Drug Resistance Mutations in HIV Type 1 Protease and Reverse Transcriptase in Cameroon: 1995 to 2010 Review (2011) (3)
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries (2021) (3)
In Vitro Antimicrobial Characterization of Lactobacillus Isolates Towards Their Use as Probiotic Alternatives to Antibiotic Growth Promoters (2019) (3)
Characterizing disability and perception of rehabilitation in the health District of Dschang, Cameroon (2016) (3)
HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Crosssectional Design (2017) (3)
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals. (2022) (3)
Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection. (2011) (3)
[Study of knowledge, attitudes and practices in social reintegration of women victims of obstetric fistula: region of the far-North, Cameroon]. (2015) (2)
Archiving of mutations in HIV‐1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP‐READY study (2021) (2)
Structural Differences in KIR3DL1 and LILRB1 Interaction with HLA-B and the Loading Peptide Polymorphisms: In Silico Evidences (2015) (2)
Population-Based Surveillance of Hiv-1 Drug Resistance in Cameroonian Adults Initiating Antireviral Therapy According to the World Health Organization Guidelines (2015) (2)
Decreased Inaccuracies in HIV Screening following Strengthening of Quality System: Evidence-based Interventions through the PMTCT Program in Cameroon (2019) (2)
HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design. (2016) (2)
Exogenous miRNAs from Moringa oleifera Lam. recover a dysregulated lipid metabolism (2022) (2)
Individual and area-based socioeconomic influences on HIV seroprevalence in Cameroon (2013) (2)
Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000 (2022) (2)
Viral Hepatitis B and C Detection among Ebola Survivors and Health Care Workers in Makeni, Sierra Leone (2020) (2)
In vivo assessment of protein quality and safety of meat derived from broilers fed diet supplemented with probiotics used as substitute to antibiotics (2019) (2)
[The burden of disability in Cameroon]. (2017) (2)
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain (2014) (2)
Lower anti-HIV-1 neutralization in HIV-infected children with CD4+ T cell depletion: opposite correlation to that in adults. (2014) (1)
152 HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON (2012) (1)
The Ebola virus disease outbreak in Tonkolili district, Sierra Leone: a retrospective analysis of the Viral Haemorrhagic Fever surveillance system, July 2014–June 2015 (2019) (1)
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings (2022) (1)
Poor Acceptability of Female Condom by Young Cameroonians: an Unmet Programmatic Agenda for HIV Prevention. (2016) (1)
TRIM5α 136Q, CCR5 Promoter 59029G And CCR264I Alleles Impact The Progression Of HIV In Children And Adolescents (2019) (1)
High concordance in SARSCoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon (2022) (1)
HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol (2020) (1)
PO 8580 TREATMENT RESPONSE AMONG CAMEROONIAN ADOLESCENTS RECEIVING ANTIRETROVIRAL THERAPY IN URBAN AND RURAL SETTINGS: PRELIMINARY FINDINGS FROM THE READY STUDY (2019) (1)
The 2nd International Conference on Public Health in Africa 12-15 December 2022, Kigali Rwanda (2023) (1)
[BCG vaccination and development of an innovative vaccine for preventing vertical HIV transmission in Africa]. (2006) (1)
Microbiological quality and genotoxicity of domestic water sources: A combined approach using Micro Biological Survey method and mutagenesis assay (micronucleus test) in root tips of Vicia faba in the West region of Cameroon (2021) (1)
Validation of a single-platform, volumetric, flow cytometry for CD4 T cell count monitoring in therapeutic mobile unit (2012) (1)
HIV-1 Drug Resistance and Genetic Diversity among Vertically Infected Cameroonian Children and Adolescents (2020) (1)
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis (2022) (1)
Libya should stop denying scientific evidence on HIV (2007) (1)
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients (2022) (1)
Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000) (2022) (1)
Enigma of the high prevalence of anti-SARS-CoV-2 antibodies in HIV-positive people with no symptoms of COVID-19 in Burkina Faso (2022) (1)
Promoting Responsible Research and Innovation (RRI) During Brazilian Activities of Genomic and Epidemiological Surveillance of Arboviruses (2021) (1)
The problem of lost to follow-up of mother-child pairs enrolled in the PMTCT program in Dschang District Hospital-Cameroon. (2018) (1)
A PCR method for the identification of hepatitis A virus in Mytilus galloprovincialis. (2000) (0)
Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children (2019) (0)
Pap Test Screening among Vertically HIV-Infected Young Women (2013) (0)
[Clinical-experimental models for the identification of immunologic parameters to be integrated in traditional staging systems of colorectal neoplasms]. (1994) (0)
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model (2022) (0)
Clonal Selection and Population Dynamics of Vγ2/Vδ2 T Cells in Macaca Fascicularis (2005) (0)
Use of the ''Polymerase Chain Reaction'' for the diagnosis of Helicobacter pylori infection. (1996) (0)
Characterization of viral reservoirs in adolescents with HIV-1 non-B vertical infection receiving antiretroviral therapy: A study protocol for an observational and comparative study in Cameroon, the “EDCTP AVIR Study” (Preprint) (2022) (0)
Epigenetics in Infection, Diets, and Environment: Responsible Research and Innovation (2019) (0)
HPV Positivity and Risk of Cervical Cancer according to HIV-Infection: A Comparative Assessment in the Population of Cameroonian Women (2021) (0)
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens (2020) (0)
Identification of Laboratory Biomarkers for Early Detection and Clinical Management of Post-Acute Syndrome Among Survivors of the 2013–2016 West Africa Ebola Outbreak in Sierra Leone (2023) (0)
Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé (2019) (0)
Nutrition Habits and Health Outcomes of Breastfeeding HIV-positive mothers in the Dschang Health District, West Region Cameroon. (2016) (0)
PO 8397 VIRAL SUPPRESSION AMONG CAMEROONIAN ADULTS, ADOLESCENTS AND CHILDREN RECEIVING ANTIRETROVIRAL THERAPY IN THE ‘TEST & TREAT’ ERA (2019) (0)
Evaluation of the Quality of Cervico-Vaginal Smears at Gyneco-Obstetric and Pediatric Hospital of Douala (2019) (0)
Challenges implementing high containment laboratory during an Ebola virus disease epidemic outbreak in resource-limited setting: Our experience in Sierra Leone (2019) (0)
High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad (2023) (0)
Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic. (2023) (0)
Publisher Correction: Identification of microRNAs and relative target genes in Moringa oleifera leaf and callus (2019) (0)
Assessment of attitudes and practices of rural women towards malaria in western region, Cameroon: Strategic implications for prevention programs (2014) (0)
A High Density of Mutations within HLA Class I and II HBsAg/RT Epitopes Characterizes HBV Variants Emerging during Immune-Suppression Driven HBV Reactivation (2016) (0)
Preventing future pandemics and epidemics through a North-South collaboration on genomic surveillance in Africa (2022) (0)
SMAC, a computational system to link literature, biomedical and expression data (2019) (0)
Launch of the Laboratory for Major Tropical Epidemics (LAGET) in Chad: Strengthening the capacity for epidemiological surveillance, monitoring and diagnosis of endemic or emerging infectious diseases in Central Africa (2023) (0)
Immunoglobulin G Specific Antibody Level against Ebola Viral Glycoprotein and Nucleoprotein in Ebola Virus Disease Survivors and Their Relatives (2021) (0)
Europe and Africa: One continent in the university education The ERASMUS+ Programme (2023) (0)
Mobile health clinic for the medical management of clinical sequelae experienced by survivors of the 2013–2016 Ebola virus disease outbreak in Sierra Leone, West Africa (2017) (0)
Characterization of the Viral Reservoirs Among HIV-1 Non-B Vertically Infected Adolescents Receiving Antiretroviral Therapy: Protocol for an Observational and Comparative Study in Cameroon (2022) (0)
Mass screening for hepatitis B and C viruses in a population of persons with disabilities with and without HIV status in Cameroon. (2021) (0)
Delivering HIV treatment & care in resource limited settings - Therapeutic mobile units (2012) (0)
Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon (2020) (0)
Current practice of epidemiology in Africa: highlights of the 3rd conference of the African epidemiological association and 1st conference of the Cameroon society of epidemiology, Yaoundé, Cameroon, 2014 (2015) (0)
Olea europaea small RNA with functional homology to human miR34a in cross-kingdom interaction of anti-tumoral response (2018) (0)
Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status (2023) (0)
Speaker presentations of the 2018 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) (2018) (0)
RMHP_A_327616 4923..4930 (2021) (0)
Guidelines on RRI implementation in biosciences organisations (2019) (0)
Assessment of T cell immune responses towards HIV-1 epitopes designed by reverse immunogenetic approach: proof-of-concept in HIV+ Cameroonian children (2012) (0)
Anti-toxoplasmic Immunoglobulin G Quantitation Correlates with Immunovirological Parameters of HIV-Infected Cameroonians. (2020) (0)
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With C (0)
The 2019 Cameroon University Games: Prevention Strategies for Musculoskeletal Injuries (2021) (0)
High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness (2022) (0)
M. Tuberculosis enhances iNOS mRNA expression and HIV replication in human astrocytoma cells (1997) (0)
HIV and HBV infection in Cameroonian university context: Case of the University of Dschang (2014) (0)
Role of monocytes/macrophages apoptosis during Mycobacterium tuberculosis infection (1997) (0)
Effects of environmental, living space and climate variability on the utilization of impregnated bed nets in west Cameroon: A community based survey for policy implementation (2016) (0)
Expression Level of Plasma Soluble Toll like Receptor 2 and 6 in the Mother toChild Transmission of Human Immunodeficiency Virus Type 1 (2018) (0)
HIV-infected patients , current guidelines issued by the US Public Health Service and the Infectious Diseases Society of America call for more intensive screening in (2013) (0)
Occurrence and Dietary Risk Assessment of Mycotoxins in Most Consumed Foods in Cameroon: Exploring Current Data to Understand Futures Challenges (2023) (0)
High viremia and Poor Immunity are Potential Surrogates of Anti-toxoplasmic Immunoglobulin G Quantification among HIV-Infected Individuals: A Cross-sectional Study in Yaoundé, Cameroon (2020) (0)
Repertoire selection and effector functions of neonatal {gamma}{delta} T cells (2010) (0)

This paper list is powered by the following services:

Other Resources About Vittorio Colizzi

en.wikipedia.org

What Schools Are Affiliated With Vittorio Colizzi?

Vittorio Colizzi is affiliated with the following schools:

Vittorio Colizzi's Academic­Influence.com Rankings

Vittorio Colizzi's Degrees

Why Is Vittorio Colizzi Influential?

Vittorio Colizzi's Published Works

Published Works

Other Resources About Vittorio Colizzi

What Schools Are Affiliated With Vittorio Colizzi?

Vittorio Colizzi's AcademicInfluence.com Rankings